Compare ICCC & IPWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICCC | IPWR |
|---|---|---|
| Founded | 1982 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.5M | 42.8M |
| IPO Year | 1987 | 2013 |
| Metric | ICCC | IPWR |
|---|---|---|
| Price | $5.48 | $4.17 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.75 |
| AVG Volume (30 Days) | 20.0K | ★ 87.9K |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | ★ $27,769,304.00 | $43,136.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $3,233.33 |
| P/E Ratio | $21.85 | ★ N/A |
| Revenue Growth | ★ 16.49 | N/A |
| 52 Week Low | $4.28 | $3.06 |
| 52 Week High | $7.60 | $8.62 |
| Indicator | ICCC | IPWR |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 49.16 |
| Support Level | $4.72 | $3.06 |
| Resistance Level | $5.36 | $4.06 |
| Average True Range (ATR) | 0.31 | 0.34 |
| MACD | 0.11 | 0.06 |
| Stochastic Oscillator | 81.36 | 73.25 |
ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.
Ideal Power Inc is pioneering the development of its broadly patented bidirectional power switches, creating efficient and ecofriendly energy control solutions for electric vehicles, electric vehicle charging, renewable energy, energy storage, UPS / data center, solid-state circuit breaker and other industrial and military applications. The company is focused on its patented Bidirectional, Bipolar Junction Transistor (B-TRAN) semiconductor technology. B-TRAN is a double-sided bidirectional AC switchable to deliver substantial performance improvements over conventional power semiconductors. The primary raw material used in the fabrication of B-TRAN devices is silicon wafers.